Skip to content

KDK KDK Proceeds from issuance of simple agreements for future equity

Proceeds from issuance of simple agreements for future equity at other companies

Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$0-100%
American Superconductor logo
American SuperconductorAMSC
$124.58M
JAN
Janus Living JAN
$212.75K
Phathom Pharmaceuticals, Inc. logo
Phathom Pharmaceuticals, Inc.PHAT
$121.97M
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$57.3M+2,457%

Other financials

Income statement

See full
Revenue$1.8M+24.4%
Operating income-$37.9M-104%
Net income$26.5M+121%
EPS (diluted)$0.10+105%

Balance sheet

See full
Cash & equivalents$66.4M+247%
Total debt$58.4M+1,068%
Total equity-$245.9M+34.7%
Total assets$130.8M-76.5%

Cash flow

See full
Operating cash flow-$29.5M-78.7%
CapEx$5.5M+138%
Free cash flow-$35.0M-86.0%

Valuation

See full
Market cap$1.05B-18.6%
Enterprise value$1.04B
P/S252.8×

Profitability

See full
Operating margin-2,695.8%
Net margin-10,366.9%
FCF margin-278%

Returns & leverage

See full
Return on equity-21.5%
Debt / equity-0.2×
Current ratio3.7×+3.4×

Where this comes from

Reported directly by KDK in its filing.

Tagged under the XBRL concept kdk:ProceedsFromIssuanceOfSimpleAgreementsForFutureEquity.

The official record: KDK’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about KDK's proceeds from issuance of simple agreements for future equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KDK's proceeds from issuance of simple agreements for future equity?
KDK (KDK) reported proceeds from issuance of simple agreements for future equity of $0 in Q1 2026.
How has KDK's proceeds from issuance of simple agreements for future equity changed year-over-year?
KDK's proceeds from issuance of simple agreements for future equity decreased by 100.0% year-over-year, from $21.66M to $0.
What does proceeds from issuance of simple agreements for future equity mean?
This represents the cash inflows received from the issuance of Simple Agreements for Future Equity (SAFEs) to investors. These instruments provide immediate capital in exchange for the right to receive equity in a future financing round or liquidity event. It serves as a measure of the company's ability to raise early-stage capital without immediate valuation or dilution terms.